Last reviewed · How we verify
NCT04945746
Dispersion Stability
NA trial testing AF ablation in Atrial Fibrillation in 35 participants. Participants enrolled and being followed up; not accepting new ones.
28 October 2023
Quick facts
| Lead sponsor | Hospital St. Joseph, Marseille, France |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 35 |
| Start date | 5 August 2021 |
| Primary completion | 28 October 2023 |
| Estimated completion | 28 January 2025 |
| Sites | 1 location across France |
Drugs / interventions tested
- AF ablation
Conditions studied
- Atrial Fibrillation — all drugs for Atrial Fibrillation →
Sponsor
Hospital St. Joseph, Marseille, France
Who can join
18 and older, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To assess the acute efficacy of ablation of the most stable VX1 areas (levels 2 and 3) in terms of the rate of acute AF termination. Identify the spatial distribution of dispersion stability levels based on VX1. Document the rate of adverse events. To assess the long-term efficacy of ablation of the most stable VX1 areas in terms of the absence of documented arrhythmias during a 12-month follow-up.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04945746
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of AF ablation
Trials testing the same drug.
- NCT06719921 — Catheter Ablation for Atrial Fibrillation in Non-Fluoroscopic Lab · NA · enrolling by invitation
- NCT04592497 — Evaluation of the Safety and Performance of the Very High Power-Short Duration QDOT · NA · unknown
- NCT05827172 — AF Ablation for HF With Reduced EF · NA · completed
- NCT03989726 — Efficacy of High Density Voltage and Fractionation Map Guided Ablation in Patients With Atrial Fibrillation · NA · unknown
- NCT03607123 — Atrial Fibrillation With Sinus Node Dysfunction: Intensive Device Follow-up · unknown
Other recruiting trials for Atrial Fibrillation
Currently open trials in the same condition.
- NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
- NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
- NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
- NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
- NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting
Other Hospital St. Joseph, Marseille, France trials
Trials by the same sponsor.
- NCT05779735 — Validation of Ultrasound "Angle of Progression" Measurement to Decrease the Cesarean Rate · NA · unknown
- NCT05662657 — Prevalence of Post Traumatic Stress Disorder Related to Diabetes Diagnosis or Severe Hypoglycaemia in Adult With Type 1 · completed
- NCT05068973 — Evaluation of the NOVATECH ® LUCIOLA TM EB Fiducial Marker During Radiotherapy Sessions in Lung Cancer Patients · NA · unknown
- NCT04672642 — Evaluation of the SpyGlass DS for Detection of Residual Pancreatic Calculations · NA · completed
- NCT04839627 — Impact of Serum Progesterone Levels on the Day of Fresh and Frozen Embryo Transfer on the Ongoing Pregnancy Rates. · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04945746 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital St. Joseph, Marseille, France
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04945746.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing